CNCR Holdings

The Cancer Immunotherapy ETF

ETF Information as of 10/12/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
MERCK & CO INC MRK 58933Y105 37,561 $2,622,133.41 5.37%
FATE THERAPEUTICS INC FATE 31189P102 190,374 $2,571,952.74 5.27%
NOVARTIS A G NVS 66987V109 30,239 $2,503,184.42 5.13%
BRISTOL MYERS SQUIBB CO BMY 110122108 43,409 $2,496,451.59 5.11%
GILEAD SCIENCES INC GILD 375558103 32,519 $2,393,073.21 4.90%
ASTRAZENECA PLC AZN 046353108 63,856 $2,372,250.40 4.86%
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAP 00653A107 187,588 $2,327,967.08 4.77%
IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 175,491 $2,093,607.63 4.29%
CELLECTIS S A CLLS 15117K103 73,818 $1,995,300.54 4.09%
NEKTAR THERAPEUTICS NKTR 640268108 40,750 $1,993,082.50 4.08%
MIRATI THERAPEUTICS INC MRTX 60468T105 46,524 $1,980,991.92 4.06%
XENCOR INC XNCR 98401F105 56,162 $1,967,916.48 4.03%
MACROGENICS INC MGNX 556099109 102,164 $1,931,921.24 3.96%
MORPHOSYS AG MOR 617760202 80,081 $1,869,891.35 3.83%
ZYMEWORKS INC ZYME 98985W102 139,144 $1,842,266.56 3.77%
ATARA BIOTHERAPEUTICS INC ATRA 046513107 50,356 $1,833,965.52 3.76%
ADURO BIOTECH INC ADRO 00739L101 298,527 $1,815,044.16 3.72%
ARCUS BIOSCIENCES INC RCUS 03969F109 143,131 $1,780,549.64 3.65%
FIVE PRIME THERAPEUTICS INC FPRX 33830X104 130,310 $1,707,061.00 3.50%
BEIGENE LTD BGNE 07725L102 13,141 $1,666,804.44 3.41%
DYNAVAX TECHNOLOGIES CORP DVAX 268158201 144,729 $1,633,990.41 3.35%
BLUEBIRD BIO INC BLUE 09609G100 11,670 $1,471,470.30 3.01%
CYTOMX THERAPEUTICS INC CTMX 23284F105 91,581 $1,446,063.99 2.96%
ZIOPHARM ONCOLOGY INC ZIOP 98973P101 538,325 $1,372,728.75 2.81%
SORRENTO THERAPEUTICS INC SRNE 83587F202 312,148 $1,120,611.32 2.30%
Cash & Other Cash&Other Cash&Other 9,479.40 $9,479.40 0.02%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities